overall

Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer

LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows an outstanding safety performance with a five-star result…

6 days ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

1 week ago

Medit recognized as the top brand in a global brand perception study by an external insights agency

Global sentiment analysis of 3,800 discussions from Reddit's r/Dentistry community highlights strong user recognition in software usability, workflow flexibility, and…

2 weeks ago

Sopra Steria recognised as “Leader” by NelsonHall for its ability to deploy GenAI in support of organisations’ operational transformation

PARIS, Nov. 28, 2025 /PRNewswire/ -- Sopra Steria, a major player in the European tech sector, has been ranked among…

2 weeks ago

Cell Impact has been awarded gold medal by EcoVadis

KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was awarded silver by EcoVadis. This year, the company has…

1 month ago

OMD NAMED BEST PERFORMING GLOBAL MEDIA NETWORK FOR THE TENTH CONSECUTIVE TIME

New RECMA Diagnostics Report Reveals OMD "Remains More than Ever the Leader" NEW YORK, Nov. 6, 2025 /PRNewswire/ -- In…

1 month ago

Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop

BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on fitness and overall well-being, fitness enthusiasts do much…

2 months ago

Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational…

2 months ago

PSMAddition data show Novartis Pluvicto delays progression to end-stage prostate cancer

Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition…

2 months ago

Lamborghini SC63 finishes fourth in IMSA seasonending Petit Le Mans

Mortara-Kvyat-Grosjean fight for overall victory in the 10-hour Road Atlanta marathonSant’Agata Bolognese/Braselton, GA, 12 October 2025 – The Lamborghini SC63…

2 months ago